Quanquan Gu launches Geodesic Intelligence to build AGI for drug discovery
DeryaTR_ · x · 2026-09-10
UCLA professor Quanquan Gu announced Geodesic Intelligence, an AI-native protein therapeutics startup aiming to build AGI for drug discovery — the "shortest path from biology to medicines."
- Combines frontier AI, biological foundation models, and experimental science in a full stack
- Launching today: NovaDDE and NovaAtom-Lite-Preview
The company says this is just the beginning.
Related event: UCLA's Quanquan Gu founds Geodesic to build AGI for drug discovery(4 posts)→
More from Companies & People
- Microsoft offers buyouts to 60,000 employees as AI investment shrinks headcount — dinabass · 2026-10-26
- OpenAI unifies ChatGPT, Codex and API release notes into one searchable page with RSS — craigsdennis · 2026-10-26
- Anthropic's top 2 customers fell from 54% of revenue in 2023 to about 21% by 2026 — BenBajarin · 2026-10-26
- diginomica: agentic automation hype is overdone, and 'The Hackening' of enterprise security has begun — jonerp · 2026-10-26
- Ben Bajarin: enterprise AI adoption mirrors early cloud, at magnitudes larger dollar size — BenBajarin · 2026-10-26
- An AI company built in five years now moves a mid-sized European GDP — felpix_ · 2026-10-26